Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: Main differences between two highly effective lipid-lowering therapies in subclasses of lipoproteins in patients with acute myocardial infarction

Fig. 3

Delta (final minus initial cholesterol content) in low-density lipoprotein (LDL) subfractions by lipid-lowering therapies. A The delta of LDL-1 plus LDL-2 (nonatherogenic) was similar after exposure to lipid-lowering therapies. B The delta of atherogenic LDL subfractions (LDL-3 to LDL-7) showed greater reduction by simvastatin plus ezetimibe in comparison with rosuvastatin (*P = 0.043, Mann–Whitney U test)

Back to article page